"Although the Medicare requirements ... may seem duplicative or burdensome, Medicare coverage and payment can have a positive influence on private coverage."

— From a report in Food and Drug Law Journal on clinical trial policy requirements by the Centers for Medicare & Medical Services, "Transparency, uncertainty still imbedded in FDAAA, CMS regs," p. 3.